• One-step TUNEL FITC Apoptosis Detection Kit

  2026-09-22

  The One-step TUNEL FITC Apoptosis Detection Kit uses FITC-labeled dUTP incorporation to visualize DNA fragmentation associated with apoptosis in tissue sections and cultured cells. Its fluorescence readout supports microscopy and flow cytometry, while appropriate controls are required because TUNEL detects DNA strand breaks rather than proving a single death pathway.

• c-Myc Peptide: Assay Design Beyond Tag Elution

  2026-09-22

  Discover how the c-Myc Peptide supports epitope-specific competition assays while clarifying the difference between antibody occupancy and transcription-factor biology. This article connects c-Myc tag workflows with mechanistic lessons from selective autophagy research on IRF3.

• 3X FLAG Peptide for Mechanistic Assay Design

  2026-09-21

  The 3X (DYKDDDDK) Peptide is more than a high-sensitivity epitope reagent: it can help structure purification, detection, and validation strategies for difficult protein studies. This article connects 3X FLAG workflows with the mechanistic lessons of MIGA2 lipid-transfer research while defining metal, structural, and interpretation limits.

• Sulfo-Cy5 NHS Ester for Aqueous Protein Imaging

  2026-09-21

  Sulfo-Cy5 NHS ester enables bright, aqueous-phase labeling of amine-containing proteins and peptides without relying on organic co-solvents. This article translates its spectral and solubility advantages into practical workflows for cellular imaging, uptake assays, and immune-microenvironment studies inspired by recent nanostructure research.

• From Epigenetic Silence to Translational Strategy in OS

  2026-09-20

  A thought-leadership analysis of how RUNX2-driven chromatin repression limits interferon signaling and immune checkpoint blockade in osteosarcoma, with practical guidance for validating the pathway and responsibly exploring Repaglinide in a separate metabolic-context arm.

• Trichostatin A: From HDAC Inhibition to Tumor Immunity

  2026-09-19

  Trichostatin A (TSA) is more than a proliferation tool: it can help dissect how HDAC-dependent chromatin states influence tumor immunogenicity. This article connects TSA assay design with the CBX2–RACK1–HDAC1 pathway and highlights practical controls, readouts, and limitations.

• RHEB Neddylation Activates mTORC1 in Liver Cancer

  2026-09-18

  The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation machinery and maps the modification to lysine 169. By connecting RHEB neddylation with lysosomal localization, GTP binding, mTORC1 activity, and PTEN-loss-driven liver tumorigenesis, the work expands the functional scope of neddylation beyond cullin regulation.

• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-18

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that reinforces suppressive tumor-associated macrophage states. Their work connects lysosomal lipid handling to the GPR155–mTORC1–AMPKα–STAT6 pathway and shows how CH25H targeting can improve T-cell surveillance and anti-PD-1 responses.

• Lyso-Tracker Red for Nanovaccine Trafficking

  2026-09-17

  Use Lyso-Tracker Red to convert nanovaccine trafficking into a measurable live-cell readout of acidic-compartment entry, retention, and apparent escape. This workflow complements immune-endpoint assays by connecting CLam/OVA particle design with dendritic-cell localization and lysosomal behavior.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Uses

  2026-09-17

  This dual-fluorescence reporter separates mRNA uptake from functional translation in one experiment. It enables quantitative nanoparticle validation, macrophage-delivery screening, trafficking studies, and faster optimization of gene-delivery workflows.

• Trifluoperazine 2HCl: From D2 to Host Defense

  2026-09-16

  Trifluoperazine 2HCl offers translational researchers a high-affinity dopamine D2 receptor probe for connecting dopaminergic signaling pathway modulation with emerging host-directed antibacterial research. This article examines the mechanistic rationale, experimental controls, evidence boundaries, and strategic opportunities for using the compound across neuropharmacology, immunology, and cancer-related models.

• GW 4869 (hydrochloride hydrate) for Reliable Assays

  2026-09-16

  Learn how GW 4869 (hydrochloride hydrate), SKU C4769, can support controlled studies of neutral sphingomyelinase, ceramide signaling, extracellular-vesicle release, and cell injury. This scenario-based guide connects formulation details with practical viability-assay controls and evidence from lupus nephritis research.

• FOLR3 Amplifies TGFβ Signaling in NASH Fibrosis

  2026-09-15

  This preprint identifies secreted folate receptor-gamma (FOLR3) as a human-associated driver of fibrogenesis in nonalcoholic steatohepatitis, linking its interaction with HTRA1 to enhanced TGFβ signaling in hepatic stellate cells. The findings suggest that FOLR3 may be both a fibrosis-associated biomarker and a mechanistic target, although species differences and the preprint status require careful interpretation.

• Calpeptin: Calpain Inhibitor for Fibrosis Research

  2026-09-15

  Calpeptin is a nanomolar calpain inhibitor with a reported IC50 of 5 nM for human calpain 1. Evidence supports its use in calpain, extracellular-vesicle, pulmonary fibrosis research, and fibrosis and inflammation modulation, but biochemical potency must not be treated as a universal cellular dose.

• 3X (DYKDDDDK) Peptide: From Tag to Assay Control

  2026-09-14

  The 3X (DYKDDDDK) Peptide is more than an epitope label: it can serve as a control element for purification, immunodetection, structural biology, and metal-sensitive assays. This article connects its assay utility with mechanistic lessons from nimbolide chemoproteomics and targeted protein degradation.

8069 records 1/538 page Next 12345 下5页 Last page